NATIONAL CANCER INSTITUTE
Desconocido
SCARLET: Scaling up early and late effects research in Lithuanian childhood cancer survivors through educatio...
NACIONALINIS VEZIO INSTITUTAS
participó en un
HORIZON EUROPE:
HORIZON-WIDERA-2023-ACCESS-02
The SCARLET (SCAling up early and late effects Research in Lithuanian childhood cancer survivors through Education and Twinning) proposal ai...
2024-05-07 - 2027-09-30 | Financiado
2024-05-07 - 2027-09-30 | Financiado
ProCAncer-I: An AI Platform integrating imaging data and models supporting precision care through prostate cance...
NACIONALINIS VEZIO INSTITUTAS
participó en un
H2020:
H2020-SC1-FA-DTS-2018-2020
In Europe, prostate cancer (PCa) is the second most frequent type of cancer in men and the third most lethal. Current clinical practices, of...
2020-05-29 - 2024-09-30 | Financiado
2020-05-29 - 2024-09-30 | Financiado
* No se disponen de datos de la empresa actual.